Table 1.
Gene sequence characteristics and predicted functions of TSHSV proteins
| Protein name | Sequence information | Family membership | Homologous superfamilies | Molecular function | 3D template and description | ||||
|---|---|---|---|---|---|---|---|---|---|
| Length (bp) | MW (kDa) | pI | Template | Similarity | Description | ||||
| TSHSV-HP1 | 237 | 8.70 | 4.86 | None predicted | None predicted | None predicted | 4hkr.1.A | 34% | Calcium-release-activated calcium channel protein 1 |
| TSHSV-HP2 | 924 | 35.4 | 8.65 | None predicted | None predicted | None predicted. | 4ium.1.A | 31% | papain-like protease 2 |
| TSHSV-HP3 | 4656 | 169.6 | 6.44 | Equine arteritis virus peptidase S32 (IPR008760, 887-1139) | None predicted |
serine-type endopeptidase activity (GO:0004252); 1a replicase protein (GO:0003824) |
5y4l.1.A | 32% | Non-structural protein |
| TSHSV-HP4 | 5076 | 188.0 | 7.02 | None predicted |
P-loop containing nucleoside triphosphate hydrolase (IPR027417, 798-1042); endoribonuclease EndoU-like (IPR037227, 1412-1528) |
zinc ion binding (GO:0008270) | 4n0n.1.A | 32% | Replicase polyprotein 1ab |
| TSHSV-HP5 | 507 | 18.7 | 10.75 | None predicted | None predicted | None predicted | 3d1d.1.A | 33% | RNA-induced transcriptional silencing complex protein tas3 |
| TSHSV-HP6 | 582 | 22.5 | 9.27 | None predicted | None predicted | None predicted | 4za1.1.A | 28% | NosA |
| TSHSV-HP7 | 987 | 37.1 | 7.59 | None predicted | None predicted | None predicted | 4p85.1.A | 29% | Est-Y29 |
| TSHSV-HP8 | 2142 | 80.4 | 7.30 | None predicted | None predicted | None predicted | 3sfm.1.A | 40% | Dihydrofolapfte reductase type 2 |